生命科学资讯

Chengdu Chipscreen Pharmaceutical describes new WRN inhibitors

New CDK inhibitors disclosed in Adlai Nortye patent

Alebund Pharmaceuticals discovers new complement factor B inhibitors

Is 10x Genomics Inc. (1KJ) stock cheap vs fundamentals - Earnings Growth Report & High Return Stock Watch Alerts - Newser

Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $670 From $656, Keeps Overweight Rating - MarketScreener

The ‘clever’ tool increasingly getting bigger biotech deals signed

3,347,921 Shares in Agilent Technologies, Inc. $A Acquired by Norges Bank - MarketBeat

Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDA

Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17 - MarketScreener

Why Waters Corporation stock remains stable - 2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - Newser

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight - BioSpace

As the bio industry grows, Thermo Fisher Scientific (TMO), the world's No. 1 producer of life scienc.. - 매일경제

Is Waters Corporation stock worth holding before Fed meeting - Newser

Vandria plots Series B raise to advance Alzheimer’s drug into Phase 2

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers - Thermo Fisher Scientific

What macro factors could drive Waters Corporation (WAZ) stock higher - Earnings Summary Report & Weekly Top Gainers Alerts - Newser

Is Agilent Technologies Inc. stock good for wealth creation - July 2025 Levels & Weekly High Return Opportunities - Newser

Thermo Fisher (TMO) Raises €2.1 Billion Through Floating and Fixed-Rate Senior Notes - MSN

Will Lonza Group AG (Common Stock) (LO31) stock issue positive guidance - 2025 Price Targets & Risk Controlled Daily Plans - Newser

What MACD trends signal for Lonza Group AG (Common Stock) (LO3A) stock - Newser